MARKET

PTCT

PTCT

Ptc Therapeutics
NASDAQ
41.91
+0.75
+1.82%
Opening 15:53 05/31 EDT
OPEN
41.30
PREV CLOSE
41.16
HIGH
42.35
LOW
40.96
VOLUME
613.96K
TURNOVER
16.01M
52 WEEK HIGH
59.84
52 WEEK LOW
25.01
MARKET CAP
3.11B
P/E (TTM)
-5.3098
1D
5D
1M
3M
1Y
5Y
Ptc Therapeutics: Report of proposed sale of securities
Press release · 3d ago
Ptc Therapeutics: Statement of changes in beneficial ownership of securities
Press release · 3d ago
Ptc Therapeutics: Current report
Press release · 3d ago
Relative Strength Alert For PTC Therapeutics
NASDAQ · 6d ago
PTC Therapeutics: Rare Disease Specialist's Stock In Danger Of Slipping Further
Seeking Alpha · 6d ago
Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates
NASDAQ · 6d ago
SVB Securities Sticks to Its Hold Rating for PTC Therapeutics (PTCT)
TipRanks · 6d ago
RBC Capital Maintains PTC Therapeutics (PTCT) Sector Perform Recommendation
NASDAQ · 6d ago
More
About PTCT
PTC Therapeutics, Inc. is a science-driven, global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. Its portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology, metabolism and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It also offers Upstaza, a gene therapy for the treatment of Aromatic L-Amino Decarboxylase (AADC) deficiency, and Evrysdi, a treatment for spinal muscular atrophy (SMA). Its splicing platform includes PTC518, which is being developed for the treatment of Huntington’s disease (HD).

Webull offers kinds of PTC Therapeutics, Inc. stock information, including NASDAQ:PTCT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTCT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PTCT stock methods without spending real money on the virtual paper trading platform.